Repligen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.

About RGEN

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America.

CEO

Olivier Dominique Loeillot

CEOOlivier Dominique Loeillot

Employees

1,778

Employees1,778

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

1981

Founded1981

Employees

1,778

Employees1,778

RGEN Key Statistics

Market cap

6.75B

Market cap6.75B

Price-Earnings ratio

-465.28

Price-Earnings ratio-465.28

Dividend yield

—

Dividend yield—

Average volume

667.47K

Average volume667.47K

High today

$120.35

High today$120.35

Low today

$112.71

Low today$112.71

Open price

$115.43

Open price$115.43

Volume

470.19K

Volume470.19K

52 Week high

$182.52

52 Week high$182.52

52 Week low

$102.97

52 Week low$102.97

RGEN News

TipRanks 2d

Repligen Appoints Violetta Hughes as Chief Accounting Officer

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

78%

of 23 ratings

Buy

78.3%

Hold

21.7%

Sell

People also own

Based on the portfolios of people who own RGEN. This list is generated using Robinhood data, and it’s not a recommendation.